Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
tTF-NGR + Trabectedin in Advanced Soft Tissue Sarcoma
NCT05597917Phase 3Recruiting
- Sponsor
- Universität Münster
- Start
- Oct 2021
- Primary completion
- Aug 2026
- Modality
- Immunotoxins, Peptides, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of tTF-NGR in soft tissue sarcoma (STS), sponsored by Universität Münster. Started Oct 2021; status: recruiting.
02
Drugs
tTF-NGR
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT05597917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05597917.